A prospective, randomized comparison of promus everolimus-eluting and TAXUS Liberte paclitaxel-eluting stent systems in patients with coronary artery disease eligible for percutaneous coronary intervention: the PROMISE study.
Kim U, Lee CH, Jo JH, Lee HW, Choi YJ, Son JW, Lee SH, Park JS, Shin DG, Kim YJ, Jeong MH, Cho MC, Bae JH, Lee JH, Kang TS, Jung KT, Jung KH, Lee SW, Cho JH, Kim W, Hur SH, Kim KS, Park HS, Kim MH, Hwang JY, Kim DI, Kim TI.
Kim U, et al. Among authors: kim yj, kim w, kim di, kim ti, kim ks, kim mh.
J Korean Med Sci. 2013 Nov;28(11):1609-14. doi: 10.3346/jkms.2013.28.11.1609. Epub 2013 Oct 31.
J Korean Med Sci. 2013.
PMID: 24265523
Free PMC article.
Clinical Trial.